FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4379208003> ?p ?o ?g. }

• W4379208003 abstract "ObjectivesPostoperative atrial fibrillation is the most common clinical complication after coronary artery bypass graft surgery. It is associated with a high risk of both stroke and death and increases the length of hospital stay and costs. This study aimed to evaluate anticoagulants in postoperative atrial fibrillation.MethodsA single-center, randomized, prospective, and open-label study. The trial was conducted in Heart Institute at University of São Paulo, Brazil. Patients who developed postoperative atrial fibrillation were randomized to anticoagulation with rivaroxaban or warfarin plus enoxaparin bridging. The primary objective was the cost-effectiveness evaluated by quality-adjusted life years, using the SF-6D questionnaire. The secondary end point was the combination of death, stroke, myocardial infarction, thromboembolic events, infections, bleeding, readmissions, and surgical reinterventions. The safety end point was any bleeding using the International Society on Thrombosis and Haemostasis score. Follow-up period was 30 days after hospital discharge.ResultsWe analyzed 324 patients and 53 patients were randomized. The median cost-effectiveness was $1423.20 in the warfarin group versus $586.80 in the rivaroxaban group (P = .002). The median cost was lower in the rivaroxaban group, $450.20 versus $947.30 (P < .001). The secondary outcome was similar in both groups, 44.4% in warfarin group versus 38.5% in the rivaroxaban group (P = .65). Bleeding occured in 25.9% in the warfarin group versus 11.5% in the rivaroxaban group (P = .18).ConclusionsRivaroxaban was more cost-effective when compared with warfarin associated with enoxaparin bridging in postoperative atrial fibrillation after isolated coronary artery bypass grafting." @default.
• W4379208003 created "2023-06-04" @default.
• W4379208003 creator A5006939502 @default.
• W4379208003 creator A5012336171 @default.
• W4379208003 creator A5033029673 @default.
• W4379208003 creator A5036754221 @default.
• W4379208003 creator A5049016790 @default.
• W4379208003 creator A5057650754 @default.
• W4379208003 creator A5060183357 @default.
• W4379208003 creator A5062798181 @default.
• W4379208003 creator A5064062769 @default.
• W4379208003 creator A5080505061 @default.
• W4379208003 date "2023-06-01" @default.
• W4379208003 modified "2023-10-11" @default.
• W4379208003 title "Rivaroxaban versus warfarin in postoperative atrial fibrillation: Cost-effectiveness analysis in a single-center, randomized, and prospective trial" @default.
• W4379208003 cites W1567937563 @default.
• W4379208003 cites W1798022093 @default.
• W4379208003 cites W2006452581 @default.
• W4379208003 cites W2059852786 @default.
• W4379208003 cites W2069608457 @default.
• W4379208003 cites W2087431627 @default.
• W4379208003 cites W2088012182 @default.
• W4379208003 cites W2092052931 @default.
• W4379208003 cites W2093800201 @default.
• W4379208003 cites W2094145886 @default.
• W4379208003 cites W2106987727 @default.
• W4379208003 cites W2141616636 @default.
• W4379208003 cites W2144902508 @default.
• W4379208003 cites W2328315835 @default.
• W4379208003 cites W2762383777 @default.
• W4379208003 cites W2768170783 @default.
• W4379208003 cites W2774416601 @default.
• W4379208003 cites W2789187909 @default.
• W4379208003 cites W2887230818 @default.
• W4379208003 cites W2914381505 @default.
• W4379208003 cites W2917884932 @default.
• W4379208003 cites W2942966646 @default.
• W4379208003 cites W2957544571 @default.
• W4379208003 cites W3011371150 @default.
• W4379208003 cites W3021869599 @default.
• W4379208003 cites W3028250860 @default.
• W4379208003 cites W3080165835 @default.
• W4379208003 cites W3082188176 @default.
• W4379208003 cites W3105067746 @default.
• W4379208003 cites W3203717762 @default.
• W4379208003 cites W4283704640 @default.
• W4379208003 cites W4310817736 @default.
• W4379208003 doi "https://doi.org/10.1016/j.xjon.2023.05.006" @default.
• W4379208003 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37808050" @default.
• W4379208003 hasPublicationYear "2023" @default.
• W4379208003 type Work @default.
• W4379208003 citedByCount "0" @default.
• W4379208003 crossrefType "journal-article" @default.
• W4379208003 hasAuthorship W4379208003A5006939502 @default.
• W4379208003 hasAuthorship W4379208003A5012336171 @default.
• W4379208003 hasAuthorship W4379208003A5033029673 @default.
• W4379208003 hasAuthorship W4379208003A5036754221 @default.
• W4379208003 hasAuthorship W4379208003A5049016790 @default.
• W4379208003 hasAuthorship W4379208003A5057650754 @default.
• W4379208003 hasAuthorship W4379208003A5060183357 @default.
• W4379208003 hasAuthorship W4379208003A5062798181 @default.
• W4379208003 hasAuthorship W4379208003A5064062769 @default.
• W4379208003 hasAuthorship W4379208003A5080505061 @default.
• W4379208003 hasBestOaLocation W43792080031 @default.
• W4379208003 hasConcept C126322002 @default.
• W4379208003 hasConcept C127413603 @default.
• W4379208003 hasConcept C141071460 @default.
• W4379208003 hasConcept C164705383 @default.
• W4379208003 hasConcept C168563851 @default.
• W4379208003 hasConcept C203092338 @default.
• W4379208003 hasConcept C2776301958 @default.
• W4379208003 hasConcept C2778205648 @default.
• W4379208003 hasConcept C2778661090 @default.
• W4379208003 hasConcept C2779161974 @default.
• W4379208003 hasConcept C2780073493 @default.
• W4379208003 hasConcept C2780645631 @default.
• W4379208003 hasConcept C42219234 @default.
• W4379208003 hasConcept C500558357 @default.
• W4379208003 hasConcept C71924100 @default.
• W4379208003 hasConcept C78519656 @default.
• W4379208003 hasConceptScore W4379208003C126322002 @default.
• W4379208003 hasConceptScore W4379208003C127413603 @default.
• W4379208003 hasConceptScore W4379208003C141071460 @default.
• W4379208003 hasConceptScore W4379208003C164705383 @default.
• W4379208003 hasConceptScore W4379208003C168563851 @default.
• W4379208003 hasConceptScore W4379208003C203092338 @default.
• W4379208003 hasConceptScore W4379208003C2776301958 @default.
• W4379208003 hasConceptScore W4379208003C2778205648 @default.
• W4379208003 hasConceptScore W4379208003C2778661090 @default.
• W4379208003 hasConceptScore W4379208003C2779161974 @default.
• W4379208003 hasConceptScore W4379208003C2780073493 @default.
• W4379208003 hasConceptScore W4379208003C2780645631 @default.
• W4379208003 hasConceptScore W4379208003C42219234 @default.
• W4379208003 hasConceptScore W4379208003C500558357 @default.
• W4379208003 hasConceptScore W4379208003C71924100 @default.
• W4379208003 hasConceptScore W4379208003C78519656 @default.
• W4379208003 hasLocation W43792080031 @default.
• W4379208003 hasLocation W43792080032 @default.
• W4379208003 hasOpenAccess W4379208003 @default.
• W4379208003 hasPrimaryLocation W43792080031 @default.

• next